Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Ewa Paszkiewicz‐Kozik"'
Autor:
Piotr Glinka, Michał Sobstyl, Grzegorz Rymkiewicz, Teresa Wierzba-Bobrowicz, Ewa Paszkiewicz-Kozik, Wiesława Grajkowska
Publikováno v:
Folia Neuropathologica, Vol 62, Iss 1, Pp 102-107 (2024)
MALT lymphoma of the dura is a very rare type of low-grade B-cell lymphoma. Little more than 100 cases have been reported in the literature to date. We report a 43-year-old woman who was referred to hospital because of a series of three tonic-clonic
Externí odkaz:
https://doaj.org/article/f9354f92f6634e65894d02b2c0c9ecc7
Autor:
Maria Kulecka, Paweł Czarnowski, Aneta Bałabas, Maryla Turkot, Kamila Kruczkowska-Tarantowicz, Natalia Żeber-Lubecka, Michalina Dąbrowska, Ewa Paszkiewicz-Kozik, Jan Walewski, Iwona Ługowska, Hanna Koseła-Paterczyk, Piotr Rutkowski, Anna Kluska, Magdalena Piątkowska, Agnieszka Jagiełło-Gruszfeld, Michał Tenderenda, Cieszymierz Gawiński, Lucjan Wyrwicz, Magdalena Borucka, Maciej Krzakowski, Leszek Zając, Michał Kamiński, Michał Mikula, Jerzy Ostrowski
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8026 (2024)
The key association between gut dysbiosis and cancer is already known. Here, we used whole-genome shotgun sequencing (WGS) and gas chromatography/mass spectrometry (GC/MS) to conduct metagenomic and metabolomic analyses to identify common and distinc
Externí odkaz:
https://doaj.org/article/30b6864b982d48a4bee47b7dc00ebf5c
Autor:
Elżbieta Kalicińska, Agnieszka Giza, Jan Maciej Zaucha, Sebastian Giebel, Dagmara Zimowska‐Curyło, Iga Andrasiak, Wojciech Spychałowicz, Jerzy Wojnar, Andrzej Balcerzak, Joanna Romejko‐Jarosińska, Ewa Paszkiewicz‐Kozik, Wanda Knopińska‐Posłuszny, Justyna Rybka, Paula Jabłonowska, Tomasz Wróbel
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3036-3045 (2023)
Abstract Objective To investigate the prevalence of histopathological subtypes, the clinical stage at presentation and treatment modalities in Polish patients with orbital lymphoma (OL) and to determine prognostic outcomes. Methods The retrospective
Externí odkaz:
https://doaj.org/article/8bfcff17849f4c5cb3b258376f77adc4
Autor:
Muhit Ozcan, Yuqin Song, Seung Tae Lee, Felix Mensah, Dipenkumar Modi, Alexander Fossa, Won Seog Kim, Ewa Paszkiewicz-Kozik, Yazeed Sawalha, Omur Gokmen Sevindik, Lalita Norasetthada, Armando Santoro, Kumudu Pathiraja, Samhita Chakraborty, Patricia Marinello, David Lavie
Publikováno v:
HemaSphere, Vol 7, p e03345ef (2023)
Externí odkaz:
https://doaj.org/article/5aca785fd435480da499be81ff0b9ce3
Autor:
Hummaira Sadaf, Maciej Ambroziak, Robert Binkowski, Jakkapong Kluebsoongnoen, Ewa Paszkiewicz-Kozik, Jaroslaw Steciuk, Sergiusz Markowicz, Jan Walewski, Elzbieta Sarnowska, Tomasz Jacek Sarnowski, Ryszard Konopinski
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Recent discoveries shed light on molecular mechanisms responsible for classical Hodgkin lymphoma (HL) development and progression, along with features of Hodgkin – Reed and Sternberg cells (HRS). Here, we summarize current knowledge on characterist
Externí odkaz:
https://doaj.org/article/4edb823fea934c3dbeabfbd585ee956d
Autor:
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska, Jan Walewski
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Primary mediastinal B-cell lymphoma (PMBL) is currently curable in 85–95% of patients. Treatment regimens frequently used include RCHOP ± radiotherapy, DAEPOCH-R, or occasionally more intensive protocols. Here we present results of treatm
Externí odkaz:
https://doaj.org/article/390d2e0cb00f467e8bbd36aeef3cedd8
Autor:
Andrea Gallamini, Marco Picardi, Kateryna Filonenko, Manuel Gotti, Javier Núñez Céspedes, Andrea Rossi, Eva Domingo-Domènech, Agnieszka Giza, Roberto Sorasio, Livio Trentin, Mariana Bastos Oteiro, Ewa Paszkiewicz-Kozik, Ramon García Sanz, Caterina Patti, Stephane Chauvie, Fabrizio Bergesio, Luca Guerra, Alessandro Rambaldi, Ana Sureda Balari, Jan Maciej Zaucha
Publikováno v:
HemaSphere, Vol 6, Pp 10-11 (2022)
Externí odkaz:
https://doaj.org/article/4ba7ad9ce9ba478992592d8587a089f8
Autor:
Bartosz Puła, Katarzyna Pruszczyk, Ewa Pietrusza, Marta Morawska, Weronika Piszczek, Elżbieta Kalicińska, Agnieszka Szeremet, Jagoda Tryc-Szponder, Ewa Wąsik-Szczepanek, Joanna Drozd-Sokołowska, Helena Krzemień, Aleksandra Rejus, Małgorzata Gajewska, Kamil Wiśniewski, Maciej Wysocki, Alan Majeranowski, Ewa Paszkiewicz-Kozik, Paweł Steckiewicz, Łukasz Szukalski, Łukasz Bołkun, Monika Długosz-Danecka, Krzysztof Giannopoulos, Krzysztof Jamroziak, Ewa Lech-Marańda, Iwona Hus
Publikováno v:
Cancers, Vol 14, Iss 3, p 558 (2022)
Background. The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has become the cause of a worldwide pandemic, and its clinical infection course in patients with hematological malignancies may be severe. Methods. We performed a retrospectiv
Externí odkaz:
https://doaj.org/article/a3ae44288836474287dc575f5a0846df
Autor:
Beata Ostrowska, Katarzyna Domanska‐Czyz, Joanna Romejko‐Jarosinska, Michal Osowiecki, Lukasz Targonski, Lidia Poplawska, Robert Konecki, Martyna Kotarska, Marcin Szymanski, Anna Borawska, Monika Swierkowska, Anna Dabrowska‐Iwanicka, Agnieszka Druzd‐Sitek, Ewa Paszkiewicz‐Kozik, Ewa Mroz‐Zycinska, Joanna Tajer, Elzbieta Wojciechowska‐Lampka, Wlodzimierz Osiadacz, Grzegorz Rymkiewicz, Grazyna Lapinska, Marta Wojewodzka‐Mirocha, Wojciech Michalski, Jan Walewski
Publikováno v:
British Journal of Haematology. 201:663-672
Autor:
José Salvador Rodrigues de Oliveira, Guilherme Fleury Perini, Pier Luigi Zinzani, Valeria Buccheri, John Kuruvilla, Radhakrishnan Ramchandren, Nathalie A. Johnson, Ying Zhu, Todd L. Saretsky, Michael Dickinson, Armando Santoro, Andrew McDonald, Ewa Paszkiewicz-Kozik, Akash Nahar, Muhit Ozcan, Monika Raut, Naohiro Sekiguchi, Robin Gasiorowski
Publikováno v:
Blood Advances
Key Points Pembrolizumab improved health-related quality of life over brentuximab vedotin in patients with relapsed/refractory cHLPembrolizumab should be considered the preferred treatment option for relapsed/refractory cHL post-ASCT or in patients i